Search

everythinglearnresearchcommunity

for

Search:↓

Different types of facial fat affect aging and treatment outcomes; more research is needed to enhance anti-aging procedures.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Doctors need to be better prepared to assess and treat obesity in patients.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Minoxidil slows fibroblast growth and collagen production, potentially treating keloids, hypertrophic scars, and connective tissue disorders.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

Researchers found 15 new genetic links to skin traits in Japanese women.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Minoxidil treats high blood pressure and side effects can be managed.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.